Patient Stories

Melanoma diagnosis, now what?

Melanoma is one of the most common cancers found among adults, aged 15-29, in the U.S. and the deadliest if not caught early. There are emerging technologies to help identify a patient’s risk for recurrence and metastasis such as gene expression profiling. Learn about DecisionDX-Melanoma, which is a predictive test to help patients make the most informed treatment decisions.

Cutaneous Melanoma DecisionDx-Melanoma

From Fear to Confidence: DecisionDx-Melanoma. Greg’s Story of Empowerment Over a Melanoma Diagnosis

Discover Greg’s inspiring journey from a cancer diagnosis to a life of outdoor adventures, empowered by the DecisionDx-Melanoma test. Follow his path to knowledge and resilience in the face of melanoma.

Cutaneous Melanoma DecisionDx-Melanoma

Be your own advocate: Morgan England, Stage III melanoma survivor, shares her story

As a Stage III Melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.

Cutaneous Melanoma DecisionDx-Melanoma

Test

Focus Area

Format

Evidence

FILTER BY TESTS

Melanoma diagnosis, now what?

From Fear to Confidence: DecisionDx-Melanoma. Greg’s Story of Empowerment Over a Melanoma Diagnosis

Be your own advocate: Morgan England, Stage III melanoma survivor, shares her story